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P

olyamines are present at high concentrations in rapidly proliferating cells, including cancer cells (1) and protozoan parasites (2), and are taken up from the external environment via
specific transport mechanisms (3, 4). In cancer cells, the strategy
of conjugating cytotoxic agents to polyamines with the aim of
exploiting the polyamine uptake systems, as a means of facilitating
their uptake, has proven effective (4). Here, a series of compounds
containing cytotoxic anthracene (Ant) conjugated to a polyamine
was investigated for their effect on the in vitro growth of the human malaria parasite Plasmodium falciparum.
P. falciparum (3D7) parasite cultures were maintained (5) and
synchronized (6) as described previously. The anthracene-polyamine conjugates tested for their antiplasmodial effect were as
follows: Ant-4 [Ant-CH2-NH-(CH2)4-NH2], a putrescine conjugate; Ant-44 [Ant-CH2-NH-(CH2)4-NH-(CH2)4-NH2], a homospermidine conjugate; Ant-444 [Ant-CH2-NH-(CH2)4-NH(CH2)4-NH-(CH2)4-NH2], a homospermine conjugate; and
44-Ant-44 [NH2-(CH2)4-NH-(CH2)4-NH-CH2-Ant-CH2-NH(CH2)4-NH-(CH2)4-NH2], a bis-homospermidine conjugate (7)
(Table 1). A polyamine analog, N1-methylHSpd [NH2-(CH2)4NH-(CH2)4-NH-CH3], and an N-alkylated anthracene derivative,
Ant-N-butyl [Ant-CH2-NH-(CH2)3-CH3] (8) served as controls
(see structures in Table 3). The antiplasmodial activity of the compounds was determined after addition to “ring-stage” intraerythrocytic P. falciparum parasite cultures (200 l at 1% hematocrit
and 1% parasitemia in 96-well plates), which were then incubated
for 96 h at 37°C. Parasite proliferation was assessed using the
SYBR green I fluorescence assay as described elsewhere (9, 10).
Statistical significance was assessed with a two-tailed t test (Graphpad Instat, version 3.06).
All four anthracene-polyamine conjugates tested inhibited the
proliferation of P. falciparum parasites with IC50s (i.e., the concentrations at which proliferation was inhibited by 50%) ranging
from nM to low (⬍100) M (Table 1). Ant-4 was the most potent
of the compounds tested, with an IC50 of 0.64 ⫾ 0.04 M (n ⫽ 9;
Table 1). The polyamine conjugates contain the same anthracene
moiety, and the differential effects on parasite proliferation (Ant4 ⬎ Ant-444 ⬎ Ant-44 ⬎ 44-Ant-44; Table 1) may therefore be
attributed to the different conjugated polyamine moieties. The
anthracene-putrescine conjugate Ant-4 showed significantly
greater antiplasmodial potency than the N-alkylated anthracene
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derivative, Ant-N-butyl (IC50 ⫽ 1.54 ⫾ 0.12 M; n ⫽ 4; P ⬍ 0.05
[unpaired t test]), confirming a role for the polyamine moiety in
the antiplasmodial effect of the anthracene-putrescine conjugate.
Likewise, the finding that the antiplasmodial effect of N1-methylHSpd (IC50 ⫽ 1.50 ⫾ 0.12 mM; n ⫽ 3; P ⬍ 0.05 [unpaired t test])
was much less than that of Ant-4 indicates the importance of the
anthracene moiety in the antiplasmodial action of the conjugate.
Thus, both the anthracene and polyamine components play a role
in the antiplasmodial effect of the conjugates.
The uptake of Ant-4 into parasitized erythrocytes was investigated by taking advantage of the inherent fluorescence of anthracene. Deconvolution fluorescence microscopy of parasitized
erythrocytes preincubated with Ant-4 for 1 h at 37°C revealed
intense fluorescent staining of the parasite cytosol and nucleus,
with fluorescence observed neither in the erythrocyte compartment of infected erythrocytes nor in uninfected erythrocytes (see
Fig. S1 in the supplemental material). This preferential accumulation of Ant-4 into parasitized erythrocytes, with little uptake
into uninfected erythrocytes, was confirmed with flow cytometry
(not shown).
Polyamines are taken up into the intraerythrocytic malaria
parasite via a membrane-potential dependent mechanism and accumulate within the parasite (3). The interaction between the anthracene-polyamine conjugates of interest here and the mechanisms involved in polyamine uptake and accumulation in the
parasite was investigated by testing the effect of anthracene-polyamine conjugates on the uptake of radiolabeled polyamines, measured as described elsewhere (3). The putrescine conjugate Ant-4,
the homospermidine conjugates Ant-44 and 44-Ant-44, and the
homospermine conjugate Ant-444 (each at a concentration of 500
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Anthracene-polyamine conjugates inhibit the in vitro proliferation of the intraerythrocytic human malaria parasite Plasmodium
falciparum, with 50% inhibitory concentrations (IC50s) in the nM to M range. The compounds are taken up into the intraerythrocytic parasite, where they arrest the parasite cell cycle. Both the anthracene and polyamine components of the conjugates
play a role in their antiplasmodial effect.

Antiplasmodial Anthracene-Polyamine Conjugates

TABLE 1 IC50s for the inhibition of growth of P. falciparum parasites, CHO cells, and various human cancer cell lines by anthracene-polyamine
conjugatesa
Value(s)
Ant-4

Ant-44

Ant-444

44-Ant-44

R-putrescine

R-homospermidine

R-homospermine

bis-homospermine

0.64 ⫾ 0.04 (n ⫽ 9)
7.7
14.1 ⫾ 0.5 (n ⫽ 3)
20
6.3

4.3 ⫾ 0.3 (n ⫽ 5)
0.45
ND
ND
0.3

1.71 ⫾ 0.24 (n ⫽ 6)
10.6
ND
ND
7.5

21 ⫾ 5 (n ⫽ 2)
1.1
ND
ND
1.5

12
22
31
10

0.1
NA
NA
0.07

6.23
NA
NA
4.4

0.05
NA
NA
0.075

Characteristic
Polyamine-conjugated
groupb

SI
CHO/Pf
HepG2/Pf
HL-60/Pf
L1210/Pf
a

P. falciparum-infected erythrocytes (initially at the ring stage) were incubated with anthracene-polyamine conjugates over a range of concentrations at 37°C for 96 h, and the IC50s
(expressed here as M values) were determined using the malaria SYBR green I fluorescence assay. Data are derived from n independent triplicate experiments (indicated in
parentheses) ⫾ standard errors (SE) or were taken from published work as indicated. L1210 cells, mouse leukemia cells; HL-60, human leukemia cells; HepG2, human
hepatocellular liver carcinoma cells; Pf, P. falciparum parasites; SI (selectivity index) ⫽ (IC50 for Ant-4 against CHO, HL-60, L1210, or HepG2 cells)/(IC50 for Ant-4 against P.
falciparum parasites). ND, not determined; NA, not applicable.
b
“R” indicates the anthracene-conjugated moiety (7).
c
Data are from reference 14.
d
Data are from reference 13.
e
Data are from references 15 and 23.

M) all inhibited the uptake of both [3H]putrescine and
[3H]spermidine into mature isolated trophozoite-stage P. falciparum parasites over 30 min. Putrescine uptake was reduced
by 20% to 30% by the anthracene-polyamine conjugates,
whereas spermidine uptake was reduced by 60% to 95% (see
Fig. S2 in the supplemental material). The data are consistent
with the polyamine-anthracene conjugates competing with the
transport and/or intracellular accumulation of polyamines in
the parasite.
The characteristics of the antiplasmodial effect of the polyamine-anthracene conjugates were investigated in more detail using flow cytometry to monitor the progression of the parasite cell
cycle in the presence and absence of the most potent of the conjugates, Ant-4. Experiments commenced with ring-stage parasites
(1% hematocrit and 5% parasitemia), with cultures maintained at
37°C and monitored for 48 h. In untreated parasitized erythrocytes, nuclear division occurred as expected, with a reduction in
the percentage of parasites with a single nucleus (ring stage and
early trophozoite stage, corresponding to the G1 phase of the cell
cycle) and an increase in the percentage of parasites with multiple
nuclei (schizonts, corresponding to the S phase of the cell cycle)
after 24 h. After 48 h, the untreated parasites were again predominantly a single-nucleus ring-stage population, as the parasites reinvaded new erythrocytes and commenced the subsequent cycle
(Table 2). In contrast, Ant-4-treated intraerythrocytic P. falciparum parasites remained at the initial single-nucleus stage through-
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out the 48 h of incubation period with no nuclear division, indicating disruption of the parasite’s cell cycle within the first 24 h of
exposure (Table 2). Binding and stabilization of DNA by polyamines play an important role in DNA replication and nuclear
division during cell cycle progression (11). The inability of intraerythrocytic P. falciparum parasites to replicate their nuclei after
Ant-4 treatment is consistent with Ant-4 acting at the level of the
parasite’s DNA. The putrescine moiety of Ant-4 may act by displacing the functional polyamines from DNA and delivering the
anthracene moiety to the DNA, where the planar, polycyclic ring
structure of anthracene intercalates tightly but reversibly between
DNA base pairs (12), inhibiting DNA synthesis and inducing
DNA damage, as has been described previously for HL60 cells
(13).
Any effective antimalarial must exert selective toxicity for the
parasite relative to the cells of the human host. The finding here
that Ant-4 exerts a more potent antiplasmodial effect than Ant-44
contrasts with the previous finding that the proliferation of mammalian L1210 and CHO cells is inhibited more effectively by
Ant-44 than by Ant-4 (14, 15). The relative potencies of the polyamine-anthracene conjugates for P. falciparum compared to
mammalian cells are shown in Table 1. For the purpose of this
study, the toxicity of Ant-4 to mammalian cells was investigated
using human hepatocellular liver carcinoma cells (HepG2), with
cell proliferation assessed using a lactate dehydrogenase assay
(10). The IC50s obtained here for HepG2 cells, together with those
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IC50 (M ⫾ SE)
P. falciparum
CHOc
HepG2
HL-60d
L1210e

Niemand et al.

TABLE 2 Flow cytometric analysis of the effect of Ant-4 on nuclear division in intraerythrocytic P. falciparum parasitesa
% cells/population ⫾ SE
Treatment

HPT

1N

2N

3N

4N

⬎4N

Control

4
24
48

88.4 ⫾ 0.2
28.5 ⫾ 2.1
60.5 ⫾ 0.5

3.6 ⫾ 0.04
36.8 ⫾ 1.8
22.0 ⫾ 0.6

0.21 ⫾ 0.02
20.4 ⫾ 2.5
9.9 ⫾ 0.5

0.07 ⫾ 0.01
6.4 ⫾ 1.0
2.7 ⫾ 0.1

0.075 ⫾ 0.01
0.43 ⫾ 0.05
2.6 ⫾ 0.1

Ant-4 (0.64 M, 1 ⫻ IC50)

4
24
48

88.7 ⫾ 0.4
28.1 ⫾ 0.8
54.7 ⫾ 0.8

3.2 ⫾ 0.1
39.8 ⫾ 0.2
18.4 ⫾ 0.3

0.12 ⫾ 0.01
19.7 ⫾ 0.5
7.5 ⫾ 0.2

0.06 ⫾ 0.01
3.6 ⫾ 0.02
3.9 ⫾ 0.2

0.05 ⫾ 0.01
0.17 ⫾ 0.05
12.4 ⫾ 1

Ant-4 (3.2 M, 5 ⫻ IC50)

4
24
48

88.7 ⫾ 0.1
87.3 ⫾ 0.3
74.1 ⫾ 0.7

3.5 ⫾ 0.1
3.9 ⫾ 0.03
8.5 ⫾ 1.2

0.1
0.17 ⫾ 0.02
0.35 ⫾ 0.10

0.03 ⫾ 0.03
0.02 ⫾ 0.02
0.05 ⫾ 0.01

0.03 ⫾ 0.01
0.03
0.02 ⫾ 0.01

b

a

obtained previously for cancerous (HL-60 and L1210) and noncancerous (CHO) mammalian cells (13, 15), were used to calculate a “selectivity index” (SI) ⫽ (IC50 against mammalian cell
line)/(IC50 against P. falciparum parasites) for each of the different P. falciparum/mammalian cell combinations. The SI values for Ant-4 (⬎10) show selectivity toward P. falciparum parasites (16, 17) and are significantly lower than that for
chloroquine against HepG2 cells relative to W2 (chloroquineresistant) P. falciparum parasites (SI ⫽ 4,200) (18). The SI
values for the other anthracene-polyamine conjugates were below 10 (Table 1).
The predicted physicochemical and absorption, distribution,
metabolism, and excretion (ADME) properties of the anthracene-

polyamine conjugates were calculated using the Discovery Studio
Modeling Environment (Accelrys Software Inc., release 3.0) and
indicated that all compounds, except 44-Ant-44 (molecular
weight ⬎ 500), are Lipinski’s “Rule-of-5” compliant (19) (Table
3). Ant-4 has good aqueous solubility (20) and oral bioavailability
(human intestinal absorption) (21), is predicted to cross the
blood-brain barrier, with no significant metabolism by cytochrome P450 (CYP2D6), and, finally, has no significant plasma
protein binding (Table 3) (22).
In summary, the polyamine-anthracene conjugates represent
novel chemical structures that show a potent antiplasmodial effect, with at least one such compound, Ant-4, showing the requisite selectivity for P. falciparum in preference to mammalian cells.

TABLE 3 Physicochemical and ADME properties of the anthracene-polyamine conjugates predicted by the Discovery Studio Modeling
Environment (Accelrys Software Inc.)a

Conjugate

MWb

No. of
H-bond
donors

No. of
H-bond
acceptors

AlogPc

HIAd

Aqueous
solubility
levele

Blood brain
barrier
levelf

CYP2D6
predictiong

Plasma protein
binding
predictionh

Ant-4
Ant-44
Ant-444
44-Ant-44
N1-methylHSpd

280
353
424
527
176

2
3
4
6
3

0
0
0
0
0

0.8
⫺0.2
⫺1.2
⫺4.1
⫺3.6

0
1
2
3
3

4
5
5
5
5

2
3
4
4
4

No
Yes
Yes
Yes
No

No
No
No
No
No

Ant-N-butyl

264

1

0

3.2

0

2

0

Yes

Yes

a

ADME, absorption, distribution, metabolism, and excretion.
MW, molecular weight.
c
Lipophilicity indicator (expected to be ⬍5).
d
Human intestinal absorption (HIA): 0 ⫽ good absorption, 1 ⫽ moderate absorption, 2 ⫽ low absorption, 3 ⫽ very low absorption.
e
Drug likeness: 0 ⫽ extremely low, 1 ⫽ no (very low but possible), 2 ⫽ yes (low), 3 ⫽ yes (good), 4 ⫽ yes (optimal), 5 ⫽ no (too soluble).
f
Penetration of blood-brain barrier: O ⫽ very high (brain-blood ratio greater than 5:1), 1 ⫽ high (brain-blood ratio between 1:1 and 5:1), 2 ⫽ medium (brain-blood ratio between
0.3:1 and 1:1), 3 ⫽ low (brain-blood ratio less than 0.3:1), 4 ⫽ undefined (outside 99% confidence ellipse).
g
Inhibition of cytochrome P450 (CYP2D6): No ⫽ no inhibition, yes ⫽ inhibition.
h
Plasma protein binding: No ⫽ no binding, Yes ⫽ binds to plasma proteins.
b
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P. falciparum-infected erythrocytes initially at the ring stage were incubated at 37°C either with or without Ant-4 for the times specified, and nuclear division was monitored using
SYBR green I fluorescence. Ring- or early-trophozoite-stage intraerythrocytic parasites contain 1 one nucleus (1N), early schizonts contain 2 nuclei (2N), and later multinucleated
schizonts contain at least 3 nuclei (3N, 4N, and ⬎4N). The data represent averages of the results of three independent experiments and are shown ⫾ SE.
b
HPT, hours posttreatment.

Antiplasmodial Anthracene-Polyamine Conjugates

Further exploration of members of this class of compound as antimalarials is under way.
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